" class="no-js "lang="en-US"> Eyal Lifschitz - Medtech Alert
Tuesday, May 13, 2025
Eyal Lifschitz

Eyal Lifschitz

About Eyal Lifschitz

Founder and entrepreneur with years of experience establishing and managing medical technology companies and their business development efforts. This includes PharmaSys (acquired by Elan Corp. NYSE:ELN), ECR (acquired by AVX Corp. NYSE:AVX), Visioncare Ophthalmic Technologies, and BioControl Ltd. Eyal also served as a Director of Given Imaging (NASDAQ: GIVN).
Eyal is a Co-Founder & General Managing Partner at Peregrine Ventures an Israeli life sciences venture capital fund that focuses on pharmaceuticals, therapeutic devices, and medical software. On behalf of the Fund, Eyal serves on a number of boards, including CardioValve, Memic Innovative Surgery, Restore Medical, Cordio Medical, and more.

Related Story

Cordio Medical Raises $18 Million in Funding From Ceros and Peregrine Ventures to Accelerate Growth

June 28 2022

Cordio Medical, a market-leading medical speech processing platform, announced its latest successful strategic investment round […]